HeartFlow Analysis vs FibriCheck

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by HeartFlow
VS
by Qompium nv

AI Verdict

HeartFlow Analysis focuses on the non-invasive diagnosis and management of coronary artery disease (CAD) by creating 3D models of coronary arteries from CT scans to assess blood flow and plaque. FibriCheck, on the other hand, is a mobile application for detecting and monitoring cardiac arrhythmias like Atrial Fibrillation (AFib) using a smartphone's camera. While both are cardiology AI tools, HeartFlow provides detailed anatomical and functional assessment of coronary arteries, whereas FibriCheck offers remote heart rhythm monitoring for arrhythmia detection.

Choose HeartFlow Analysis if…

Choose HeartFlow Analysis if you need a non-invasive, highly accurate diagnostic tool to assess coronary artery disease (CAD) by creating personalized 3D models of coronary arteries from CT scans. This tool is ideal for evaluating the functional impact of blockages on blood flow and determining the necessity of invasive procedures like stenting or bypass surgery, especially for patients with suspected CAD or inconclusive stress tests.

View HeartFlow Analysis →

Choose FibriCheck if…

Choose FibriCheck if you require a convenient, remote monitoring solution for detecting and managing cardiac arrhythmias, particularly Atrial Fibrillation (AFib), using a patient's smartphone. This app is well-suited for early detection of irregular heart rhythms, investigating palpitations, monitoring patients after cardiac procedures, and providing longitudinal rhythm insights between clinic visits to optimize treatment.

View FibriCheck →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature HeartFlow Analysis FibriCheck
Pricing Contact vendor for pricing Available via subscription for end-users (monthly/yearly) or through licensing agreements for healthcare providers and clinical centers.
Deployment Cloud-based (AWS) Cloud-based digital application
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

FibriCheck (Tool B) appears to have a higher degree of usability for individual patients due to its smartphone-based application, allowing for convenient, on-demand heart rhythm monitoring without additional equipment. HeartFlow Analysis (Tool A) is a more complex diagnostic tool that requires a standard CT scan and subsequent analysis by trained professionals, making it less directly usable by patients for self-monitoring.

Clinical Value

Tie

HeartFlow Analysis (Tool A) offers comprehensive insights into coronary artery disease by creating personalized 3D models, performing FFRct analysis, and quantifying plaque, which has been shown to change management decisions in a significant percentage of cases and is supported by extensive peer-reviewed publications and ACC/AHA guidelines. FibriCheck (Tool B) provides valuable arrhythmia detection and monitoring via smartphone, with high accuracy for AF detection, but its scope is narrower compared to HeartFlow's detailed CAD assessment.

Pricing & Value

Tie

FibriCheck (Tool B) offers transparent subscription-based pricing for end-users and licensing agreements for healthcare providers, with clear costs for different monitoring durations. HeartFlow Analysis (Tool A) uses a fee-for-service model and requires contacting the vendor for pricing, although it is covered by Medicare and most U.S. commercial payers, and has established CMS payment rates. FibriCheck's direct-to-consumer options and clear pricing structure provide more immediate transparency and accessibility for individual patients.

Enterprise Readiness

Tie

HeartFlow Analysis (Tool A) demonstrates strong enterprise readiness with its cloud-based (AWS) deployment, established Category I CPT codes for reimbursement, and integration into over 1,800 institutions globally, including top heart hospitals. FibriCheck (Tool B) also offers a healthcare professional portal and API-based integration into EHRs and RPM platforms, indicating enterprise capabilities, but HeartFlow's extensive adoption and established reimbursement pathways suggest a more mature enterprise footprint.

Innovation

Tie

HeartFlow Analysis (Tool A) showcases significant innovation with its AI-powered 3D modeling, computational fluid dynamics for blood flow simulation (FFRct), and advanced plaque analysis, offering a non-invasive alternative to invasive procedures. FibriCheck (Tool B) is innovative in its use of smartphone camera-based PPG technology for arrhythmia detection, making cardiac monitoring highly accessible, but HeartFlow's approach to detailed anatomical and physiological assessment of CAD represents a more complex and groundbreaking application of AI in cardiology.

Support & Docs

Tie

Both tools provide adequate support and documentation. FibriCheck (Tool B) offers a help center with FAQs, user manuals for both the app and provider portal, and direct email support, with a stated response time of one business day. HeartFlow (Tool A) implies comprehensive support through its extensive clinical validation and integration into numerous healthcare systems, suggesting robust documentation and support for its complex technology, though specific details on support channels are less explicit in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature HeartFlow Analysis FibriCheck
Name HeartFlow Analysis FibriCheck
Company HeartFlow Qompium nv
Description Commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone.
Key Features AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmapu2122 Analysis for CCTA reading, Non-invasive diagnostic assessment, Personalized patient insights, Computational Fluid Dynamics (CFD) for blood flow simulation, High diagnostic accuracy Smartphone camera-based PPG technology for heart rhythm measurement, AI-powered algorithm for arrhythmia detection and analysis, Healthcare professional portal/dashboard for patient monitoring, Patient-facing mobile application, Detection of Atrial Fibrillation (AFib) and other arrhythmias, Immediate and actionable results, Ability to log blood pressure and weight, Customizable monitoring rules for healthcare providers

Videos

Demos, reviews, and walkthroughs featuring HeartFlow Analysis and FibriCheck.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

HeartFlow Analysis is designed to streamline coronary care by delivering detailed insights directly into PACS and EMR systems, suggesting an integrated workflow where CCTA scans are automatically and securely sent for analysis. FibriCheck offers integration via API for RPM platforms and can share reports in PDF format, which can be integrated into various solutions through HL7 and FHIR. FibriCheck also allows for app-to-app integration. HeartFlow's operational value depends on referral and imaging workflow. FibriCheck's customizable monitoring rules allow healthcare providers to define tailored rules for patient follow-up, individually or by group, which can create a more personalized and efficient workflow.
HeartFlow Analysis boasts high diagnostic accuracy for coronary artery disease (CAD) by providing personalized 3D models, FFRct analysis, and plaque analysis from CT scans. It has been validated in over 625 clinical studies and >650K patients, with an image acceptance rate exceeding 97%. FibriCheck, focused on arrhythmia detection, claims performance numbers in the +98% range for heart rate variability and arrhythmia classification, with less than 7% data rejection. It uses smartphone camera-based PPG technology and is clinically validated across over 100 peer-reviewed publications.
HeartFlow Analysis utilizes a secure cloud infrastructure, including encrypted transmission of image data and protected health information (PHI), and is SOC 2 Type II compliant and HITRUST certified. FibriCheck states that data is encrypted in transit and users can request data deletion, with no data shared with third parties.
HeartFlow provides unparalleled support with a dedicated team of experts to support and drive growth in CCTA programs, offering clinical, operational, technical, and financial resources. FibriCheck offers a healthcare professional portal/dashboard for patient monitoring and has a help center for frequently asked questions.
HeartFlow has been adopted by over 1,800 institutions and is supported by extensive clinical evidence, including over 625 clinical studies and >650K patients. FibriCheck has been utilized by over a million users worldwide and deployed across more than 25,000 members with one insurance partner, demonstrating measurable impact on detection and avoidable costs.
While specific audit-trail features are not detailed for HeartFlow, its secure cloud infrastructure and compliance certifications (HIPAA, SOC 2 Type II, HITRUST) suggest robust data governance. For FibriCheck, the healthcare professional portal and reporting functionalities imply a system for accessing and managing patient data, though explicit audit-trail features are not specified.
HeartFlow Analysis transforms CCTA scans into personalized 3D heart models, providing insights into plaque, stenosis, and blood flow (FFRct) to help physicians make decisions about revascularization and manage CAD. FibriCheck enables remote heart rhythm monitoring using a smartphone camera, detecting AFib and other arrhythmias, which allows for early detection and management of chronic conditions, potentially reducing unnecessary referrals and diagnostics.

Backers

Who funded each tool's parent company.

HeartFlow Analysis

AI Tool Finder
AI-powered search. Results may not be comprehensive.